GRANT ROUND UP 7/21/20 TO 7/27/20

Posted by on

DOD-AMRAA Dept. of the Army -- USAMRAA DoD Combat Readiness, Rapid Development and Translational Research Award W81XWH-20-S-CRRP
DOI-FWS Fish and Wildlife Service FY 2021 Clean Vessel Act (CVA) F21AS00153
DOS-INL Bureau of International Narcotics-Law Enforcement Strengthening Private Sector Engagement to Counter Synthetic Drug Trafficking SFOP0007230
DOS-MRT U.S. Mission to Mauritania PGO Request for Statements of Interest: Notice of Funding Opportunity PGO-MRT-FY2019-02
HHS-ACF-OHS Administration for Children and Families - OHS American Indian and Alaska Native Early Head Start Expansion and Early Head Start-Child Care Partnership Grants HHS-2020-ACF-OHS-HI-1853
American Indian/Alaska Native (AIAN) Head Start and/or Early Head Start Expansion HHS-2020-ACF-OHS-CI-R11-1845
Migrant and Seasonal Head Start (MSHS) Expansion HHS-2020-ACF-OHS-CM-R12-1847
Migrant and Seasonal Early Head Start Expansion and Early Head Start-Child Care Partnership Grants HHS-2020-ACF-OHS-HM-R12-1854
Early Head Start Expansion and Early Head Start-Child Care Partnership Grants HHS-2020-ACF-OHS-HP-1852
Head Start and/or Early Head Start Expansion - Alabama, Arkansas, California, Colorado, Georgia, Illinois, Kansas, Michigan, Mississippi, New Jersey, New York, Ohio, Oklahoma, and South Carolina HHS-2020-ACF-OHS-CH-1818
HHS-HRSA Health Resources and Services Administration AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF) HRSA-21-057
HHS-NIH11 National Institutes of Health Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) PAR-20-276
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) PAR-20-277
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) PAR-20-282
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) PAR-20-281
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) PAR-20-278
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional) RFA-AG-21-029
HHS-OPHS Office of the Assistant Secretary for Health State/Tribal/Territorial Partnership Initiative to Document and Sustain Disparity-Reducing Interventions MP-CPI-20-001
HUD Department of Housing and Urban Development 2020 Family Self-Sufficiency – Renewal NOFA FR-6400-N-04
NEH National Endowment for the Humanities Archaeological and Ethnographic Field Research 20200930-RFW
NSF National Science Foundation Re-entry to Active Research Program 20-586
Ecology and Evolution of Infectious Diseases 20-585
Division of Materials Research: Topical Materials Research Programs: Ceramics (CER), Electronic and Photonic Materials (EPM), Solid State and Materials Chemistry (SSMC) 20-588
Division of Materials Research: Topical Materials Research Programs: Biomaterials (BMAT), Condensed Matter Physics (CMP), Metals and Metallic Nanostructures (MMN), Polymers (POL) 20-589

← Older Post Newer Post →



Leave a comment

Please note, comments must be approved before they are published